Project Description

Family Allergy & Asthma

Prairie Capital Fund VI

Location Louisville, KY
Transaction Type Growth Buyout with Founder and Management
Investment Date March 2018

Provider of allergy, asthma, and immunology diagnosis and treatment

Industry Healthcare

Investment Rationale

  • Partnership with founders, physicians and management
  • Attractive market trends
  • Scalable platform with multiple growth opportunities
  • Attractive economic profile
  • Proven organic growth strategy

Value Add

  • Human Capital
  • Sales & Marketing
  • Technology
  • Infrastructure
  • Add-on Acquisitions
After shepherding  the growth of Family Allergy & Asthma over 35 years it was important to me to partner with a private equity firm that would allow us to continue to grow, but still maintain the quality and patient focused service we strive for.  Meeting the Prairie Capital team, especially Sean McNally and Tony Danielak, was like looking in the mirror in their commitment to “doing the right thing” in their partnership with us. We have not been disappointed.
James L. Sublett, MD, Co-Founder and Chief Medical Officer
Prairie Capital stood out from other investment firms by committing to a deep analysis of our industry, which allowed us to hit the ground running.  They also understand the cycle of business is not always a straight line up, and I appreciate that we work together on tangible solutions to support growth and also to ensure our success for many years.
Kay Tyler, CEO